CYP19A1 and breast neoplasm: Whereas no significant association was found in breast tumor samples (P = 0.337, t test; Fig. 1c), ER-positive breast cancer cell lines exhibited 5.1-fold lower mean CYP19A1 mRNA levels than ER-negative ones (P = 0.050; Fig. 1d).